1. Hypoxia-induced factor-1α in endometrial carcinoma: a mini-review of current evidence.
- Author
-
Dousias V, Vrekoussis T, Navrozoglou I, Paschopoulos M, Stefos T, Makrigiannakis A, and Jeschke U
- Subjects
- Disease Progression, Endometrial Neoplasms etiology, Endometrial Neoplasms pathology, Endometrium metabolism, Female, Humans, Hypoxia metabolism, Hypoxia pathology, Immunohistochemistry, Metabolic Networks and Pathways, Prognosis, Endometrial Neoplasms metabolism, Hypoxia-Inducible Factor 1, alpha Subunit metabolism
- Abstract
Despite the well-established role of hypoxia in cancer biology, the literature on its effects on endometrial cancer is scarce; it mainly refers to experimental settings rather than patient-derived results. Herein, an overview of the hypoxia inducible factor 1α (HIF-1α) biology, focusing on endometrial cancer, is presented. The molecular mechanisms possibly involved in endometrial cancer progression are presented, followed by a systematic approach to the current literature on immunohistochemistry evaluation of HIF-1α expression in endometrial carcinoma. Since no consensus has been made regarding HIF-1α evaluation, the evidence of possible involvement of HIF-1α in endometrial carcinoma prognosis is weak. After a consensus has been made, properly powered studies may be able to clarify whether HIF-1α can act as a prognosticator in endometrial carcinoma.
- Published
- 2012
- Full Text
- View/download PDF